S. Erdem Et Al. , "A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment," 10th Eurasian Hematology Oncology Congress , vol.85, İstanbul, Turkey, 2019
Erdem, S. Et Al. 2019. A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment. 10th Eurasian Hematology Oncology Congress , (İstanbul, Turkey).
Erdem, S., Ozbalak, M. M., Baykal, C., & Besisik, S., (2019). A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment . 10th Eurasian Hematology Oncology Congress, İstanbul, Turkey
Erdem, S. Et Al. "A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment," 10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 2019
Erdem, S. Et Al. "A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment." 10th Eurasian Hematology Oncology Congress , İstanbul, Turkey, 2019
Erdem, S. Et Al. (2019) . "A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment." 10th Eurasian Hematology Oncology Congress , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={S. Erdem Et Al. }, title={A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment}, congress name={10th Eurasian Hematology Oncology Congress}, city={İstanbul}, country={Turkey}, year={2019}}